Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

Nanofil syringe

Manufactured by World Precision Instruments
Sourced in United States, Germany
About the product

The Nanofil syringe is a precision instrument designed for accurate and controlled fluid delivery. It features a small-diameter tip for handling micro-volumes. The syringe is constructed with high-quality materials and components to ensure reliable and consistent performance.

Automatically generated - may contain errors

Market Availability & Pricing

The NanoFil™ syringe is officially available from World Precision Instruments through authorized distributors. Prices typically range from $168.70 to $288.00, depending on the model and distributor.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

Product FAQ

253 protocols using «nanofil syringe»

1

Assessing DWV Impact on argK Expression

2025
To assess the effect of DWV infection on argK expression, we artificially infected NEB with semi-pure DWV and maintained them under controlled conditions. NEB were injected with a DWV lysate prepared as described elsewhere [86 (link)]. Briefly, adult bees with symptomatic DWV infection were homogenized in 500 μl PBS in 1.5 ml microcentrifuge tubes. Tubes were centrifuged at 14,000 g for 10 min at 4 °C, and supernatant was clarified by adding an equal volume of chloroform. Samples were vortexed for 30 s, centrifuged at 10,000 g for 10 min at 4 °C, and supernatants were filtered through 0.22-μm sterile syringe filters (VWR, Radnor, Pennsylvania, USA). Lysates were stored in 40% glycerol at – 80 °C until use. RNA isolated from a subsample of the viral lysates was evaluated for DWV load by RT-qPCR, as described below, and for the presence of other common bee viruses by PCR, as described elsewhere [87 (link)]. NEB were cold-anesthetized at – 20 °C for 3 min and then either injected (or not) with 2.5 μl of 1X PBS containing 104 DWV copies, under a stereomicroscope (SteREO Discovery V8, Zeiss, Jena, Germany). The viral lysates were injected between the 4th and 5th abdominal segments using a beveled 33G NanoFil Needle (NF33BV-2) mounted on a 10-μl NanoFil syringe (World Precision Instruments, Berlin, Germany). After injection, each bee was manually fed 5 μl of honey bee gut homogenate, using a micropipette, to establish the same characteristic gut community in experimental individuals, as described elsewhere [88 (link)–90 (link)]. This step is important because emerging bees lack their gut microbiome. In a hive, this is quickly supplied by interaction with older worker bees [88 (link)], but in laboratory settings, this needs to be supplied experimentally, to avoid gut dysbiosis with a possible negative impact on their health and unclear (and avoidable) disturbing factor during the bioassay experiment. The freshly prepared gut homogenates were obtained by pulling the intestines from four nurse bees, homogenizing these in 500 μl 1X PBS, and diluting the homogenate 1:1 with 50% filtered sucrose/water solution. DWV-injected and non-injected controls were confined in separated disposable plastic cages (28 × 11x11 cm) and provided with pollen paste (90% w/w fresh corbicular pollen with water) and 50% filtered sucrose/water solution (w/v) ad libitum, inside an incubator at the abovementioned conditions. After 3 days, the experimental bees were sampled and stored at −80 °C until dissection.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Intravitreal Injection of AAV and Aflibercept

2025
Following FFA imaging, the mouse was maintained under anesthesia with dilated pupils. A sharp 30 G needle tip was used to create a sclerotomy approximately 1 mm posterior to the limbus. Subsequently, the drug was injected through the sclerotomy using a NanoFil syringe fitted with a 34 G blunted needle (World Precision Instruments, Inc., Sarasota, FL, USA). During the injection procedure, the retina was directly visualized with a surgical microscope, and a small plastic ring filled with 2% hypromellose was placed on the cornea.
The AAV2-EF1a-LoxP-SPRY2-2A-EGFP viral vector was produced and purified at the Korea Institute of Science and Technology (KIST, Seoul, Republic of Korea) Virus Facility, and injected at a concentration of 1 × 109 GC/uL per eye. AAV2-EGFP was also injected at the same concentration. Aflibercept was injected at a concentration of 40 μg/uL per eye. Both drugs were injected into both eyes of each mouse.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Viral Vector Injection in Rat Prelimbic Cortex

2025
We anesthetized rats with isoflurane prior to injecting adeno-associated viruses (AAVs) into the prelimbic cortex (unilateral, right hemisphere). We used the following stereotaxic coordinates from bregma for virus delivery: antero-posterior (AP), + 3.2 mm; medio-lateral (ML), ± 1.3 mm; dorso-ventral (DV), − 3.45 mm; 10° angle with blunt ear bars and nose bar set at − 3.3 mm (Model 962, David Kopf Instruments). We used Nanofil syringes (10 uL syringe and 33 g injector needle, World Precision Instruments) attached to a ultramicropump (UMP3, World Precision Instruments) and controller (Micro4, World Precision Instruments) to deliver 500 nL of virus (AAV2/1-hSyn1-GCaMP6s, 1.9E13 GC/mL) at a rate of 100 nL/min. Following surgery, we administered once daily injections of meloxicam (1 mg/kg, subcutaneous, Covetrus, formerly Butler Schein) and dexamethasone (0.2 mg/kg, subcutaneous, Covetrus, formerly Butler Schein) for three additional days post-surgery and allowed rats to recover for at least 7 days before initial behavioral training.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

BNST Calcium Dynamics in Mice

2025
During surgery, VGaT-IRES::Cre mice were continuously anesthetized with 1–2% isoflurane gas while secured in the stereotactic instrument. Mice were injected with AAV1-hSyn-FLEX-GCaMP6m (Addgene) unilaterally into the BNST (5 × 1012 titer, 350 nL volume; 100 nl/min rate; +0.3 mm anteroposterior, +0.6 mm mediolateral, −4.1 mm dorsoventral coordinates from bregma) using an UltraMicroPump, Nanofil syringes, and 35-gauge needles (Micro4; World Precision Instruments, Sarasota, FL). For DREADD experiments, VGaT-IRES::Cre mice were bilaterally injected with either AAV8-hSyn-DIO-mCherry, AAV8-hSyn-DIO-hM4Di-mCherry, or AAV8-hSyn-DIO-hM3Dq-mCherry using the same coordinates as previously described. Syringes were left in place for 10 min following injections before being slowly withdrawn. For fiber photometry, after the syringe was withdrawn, an optic fiber (400μm core diameter, 0.66 NA, Doric Lenses) was implanted slightly dorsal to the BNST (+0.3 mm anteroposterior, ±0.6 mm mediolateral, −3.9 mm dorsoventral coordinates from bregma). All implants were secured with skull screws and dental cement. Mice were given 3 days of postoperative care with daily carprofen (5 mg/kg, I.P.) and allowed 3–4 weeks of recovery before experimentation.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Intravitreal Injection Protocol for Mice

2024
Mice were euthanized by pentobarbital overdose and the head bathed in Betadine (Purdue Products, LLP, Stamford, CT). Eyes were enucleated and the surrounding tissues were cut away. For intravitreal injections, a Nanofil Syringe with a 35G Nanofil needle (World Precision Instruments, Sarasota, FL) was used to inject 6 µL of either UW solution (Bridge to Life Ltd., Northbrook IL), phosphate-buffered saline (PBS, 50 mM phosphate, 150 mM NaCl, pH 7.4) or mUW solution. Eyes were submerged fully in UW solution and stored at 4°C for 6 to 24 hours. Freshly enucleated eyes were used for baseline control samples. These were frozen or fixed for further analyses immediately following enucleation. Each series of experiments (histopathology, immunostaining, or messenger RNA [mRNA] analysis) used six eyes (randomly isolated from 3–4 mice) per treatment group. Each treatment group contained the same proportion of male and female mice.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.